Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

of these participants according to the prostate cancer diagnostic pathway currently used in the United Kingdom (high PSA level and positive MRI results). In addition, 40 of the participants with ...